New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox

Pharmacology Biochemistry and Behavior

Volumn 77, Issue 3, 2004, Pages 423-429

  Tapfer, Mariann K ^a   Sebestyen, Laszlo ^a   Kurucz, Istvan ^a   Horvath, Katalin ^a   Szelenyi, Istvan ^b   Bodor, Nicholas ^a,c  

^a TEVA PHARMACEUTICALS   (Israel)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c IVAX Corporation   (United States)

Author keywords

Brain targeting; Castration; Central vs. peripheral effect; Copulatory behavior; Estradiol; Lordosis behavior

Indexed keywords

CYCLODEXTRIN; ESTRADIOL; ESTRADIOL BENZOATE; ESTRADIOL DERIVATIVE; LUTEINIZING HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CASTRATION; CONTROLLED STUDY; COPULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; DRUG TARGETING; FEMALE; LORDOSIS; MALE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; LUTEINIZING HORMONE; MALE; ORCHIECTOMY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL BEHAVIOR, ANIMAL; TIME;

EID: 1542270285     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.11.005     Document Type: Article

References (36)

1. Anderson W.R., Simpkins J.W., Brewster M.E., Bodor N. Evidence for the reestablishment of copulatory behavior in castrated male rats with a brain-enhanced estradiol-chemical delivery system. Pharmacol. Biolchem. Behav. 27:1987;265-271.
2. Beyer C., Morali G., Naftolin F., Larsson K., Perez-Palacios G. Effect of some antiestrogens and aromatase inhibitors on androgen induced sexual behavior in castrated male rats. Horm. Behav. 7:1976;353-363.
3. Bodor N., Brewster M.E. Chemical delivery systems. Juliano R.L. Targeted Drug Delivery. Handbook of Experimental Pharmacology. vol. 100:1991;231-284 Springer, Berlin.
4. Bodor N., Buchwald P. Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems. Adv. Drug Deliv. Rev. 36:1999;229-254.
5. Beral V., Banks E., Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet. 360(9337):2002;942- 944.
6. Brewster M.E., Estes K.E., Loftsson T., Perchalski R., Derendorf H., Mullersman G.et al. Improved delivery through biological membranes XXXI: solubilization and stabilization of an estradiol chemical delivery system by modified β-cyclodextrins. J. Pharm. Sci. 77:1988;981-985.
7. Clark A.S., Roy E.J. Behavioral and cellular responses to pulses of low doses of estradiol 17-β Physiol. Behav. 30:1983;561-565.
8. Cyr M., Calon F., Morissette M., Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry Neurosci. 27:2002;12-27.
9. Estes K.S., Brewster M.E., Simpkins J.W., Bodor N. A novel redox system for CNS-directed delivery of estradiol causes sustained LH suppression in castrated rats. Life Sci. 40:1987;1327-1334.
10. Estes K.S., Brewster M.E., Bodor N. Evaluation of an estradiol chemical delivery system (CDS) designed to provide enhanced and sustained hormone levels in the brain. Adv. Drug Deliv. Rev. 14:1994;167-175.
11. Etgen A.M., Ungar S., Petitti N. Estradiol and progesterone modulation of norepinephrine neurotransmission: implications for the regulation of female reproductive behavior. J. Neuroendocrinol. 4:1992;255-271.
12. Etgen A.M., Chu H.P., Fiber J.M., Karkanias G.B., Morales J.M. Hormonal integration of neurochemical and sensory signals governing female reproductive behavior. Behav. Brain Res. 105:1999;95-103.
13. Gerber G.S., Zagaja G.P., Ray P.S., Rukstalis D.B. Transdermal estrogen in the treatment of hot flushes in men with prostate cancer. Urology. 55:2000;97-101.
14. Hogervorst E., Yaffe K., Richards M., Huppert F. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst. Rev. (3):2002;CDOO3799.
15. Hosoda T., Nakajima H., Honjo H. Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death. NeuroReport. 12(9):2001;1965-1970.
16. 3H-uridine incorporation in rat brain. Mol. Cell Endocrinol. 45:1986;57-63.
17. Kaplan N.M. Cardiovascular complications of oral contraceptives. Annu. Rev. Med. 29:1978;367-394.
18. Krey L.C., Kamel F., Mc Ewen B.S. Parameters of neuroendocrine aromatization and estrogen receptor occupation in male rat. Brain Res. 193:1980;277-283.
19. Lobo R.A. Benefits and risks of estrogen replacement therapy. Am. J. Obstet. Gynecol. 173:1995;982-989.
20. Low A.K., Russel L.D., Holman H.E., Shepherd J.M., Hicks G.S., Brown C.A. Hormone replacement therapy and coronary heart disease in women: a review of the evidence. Am. J. Med. Sci. 324(4):2002;180-184.
21. Luine V. Sex differences in chronic stress effects on memory in rats. Stress. 5(3):2002;205-216.
22. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91:2001;2785-2801.
23. Pitha J., Milecki J., Fales H., Pannell L., Uekama K. Hydroxypropyl-β-cyclodextrin: preparation and characterization, effects on solubility of drugs. Int. J. Pharm. 29:1986;73-82.
24. Rasia-Filho A.A., Peres T.M., Cubilla-Gutierrez F.H., Lucion A.B. Effect of estradiol implanted in the corticomedial amygdala on the sexual behavior of castrated male rats. Braz. J. Med. Biol. Res. 24(10):1991;1041-1049.
25. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L.et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 288:2002;321-333.
26. Ruggiero R.J., Likis F.E. Estrogen: physiology, pharmacology and formulations for replacement therapy. J. Midwifery Women's Health. 47(3):2002;130-138.
27. Sarkar D.K., Friedman S.J., Yen S.S., Frautschy S.A. Chronic inhibition of hypothalamic-pituitary-ovarian axis and body weight gain by brain-directed delivery of estradiol-17 beta in female rats. Neuroendocrinology. 50:1989;204-210.
28. Sarrel P.M., Lufkin E.G., Oursler M.J., Keefe D. Estrogen actions in arteries, bone and brain. Sci. Med. 1994;44-53.
29. Siegal S. Nonparametric Statistics for the Behavioral Sciences. 1956;McGraw-Hill, New York.
30. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J.et al. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87(5):1997;724-730.
31. Szejtli J. Cyclodextrins and their inclusion complexes. Budapest: Akademia Press; 1982.
32. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Rev. 37:2001;313-319.
33. Yager J.D., Liehr J.G. Molecular Mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36:1996;203-232.
34. Yen S.S. The biology of menopause. J. Reprod. Med. 18(6):1977;287-296.
35. Zar J.H. Biostatistical analysis. 1974;Prentice Hall, Englewood Chiffs, NJ.
36. Zipse L.R., Brandling-Bennett E.M., Clark A.S. Paced mating behavior in the naturally cycling and the hormone-treated female rat. Physiol. Behav. 70:2000;205-209.